Skip to main content
Springer Nature Link
Log in

Raynaud’s phenomenon in a healthy Turkish population

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Raynaud’s phenomenon (RP) is a vasospastic disease and is characterized by ischemia of the digits, nose, and ears. The vasospasm can be triggered by cold weather, cold water, or emotional stress and is followed by triphasic color changes. First white color (ischemia), then blue color (congestion and cyanosis), and finally red color change (reactive hyperemia) can be observed. The prevalence is reported to be between 0.5 and 20% in different studies and is dependent on genetic, occupational, and environmental factors. The purpose of our study was to determine the prevalence of RP in an eastern part of Turkey among healthy subjects. A total of 768 people were included in the study. This cross-sectional study was conducted between April 2003 and October 2003 at the University Hospital and at the State Hospital in Van, Turkey. The participants were interviewed and examined to diagnose RP and a questionnaire and color charts were used. Of these 768 patients, 25 women and 20 men were diagnosed to have RP. A female predominance (25/20) was observed. Their mean age was 24.78±5.71 years. The prevalence of RP was 5.9% in our study population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Klippel JH, Dieppe PA (1994) In: Rheumatology. London. Mosby, London, pp 6.8.1–6.8.3

  2. Gilliland BC (1998) Systemic sclerosis (scleroderma). In: Fauci AS, Braunwald E, Isselbacher KJ et al (eds) Harrison’s principles of internal medicine, 14th edn. International edition. McGraw-Hill, New York, pp 1888–1895

    Google Scholar 

  3. Block JA, Sequeira W (2001) Raynaud’s phenomenon. Lancet 357:2042–2048

    CAS  PubMed  Google Scholar 

  4. Brennan P, Silman A, Black C, Bernstein R, Coppock J, Maddison P et al (1993) Validity and reliability of three methods used in the diagnosis of Raynaud’s phenomenon. The UK Scleroderma Study Group. Br J Rheumatol 32:357–361

    CAS  PubMed  Google Scholar 

  5. Voulgari PV, Alamanos Y, Papazisi D, Christou K, Papanikolaou C et al (2000) Prevalence of Raynaud’s phenomenon in a healthy Greek population. Ann Rheum Dis 59:209–210

    Google Scholar 

  6. Hladunewich M, Sawka C, Fam A, Franssen E (1997) Raynaud’s phenomenon and digital gangrene as a consequence of treatment for Kaposi’s sarcoma. J Rheumatol 24:2371–2375

    CAS  PubMed  Google Scholar 

  7. Seibold JR (1993) Scleroderma. In: Kelley WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of rheumatology, 4th edn. WB Saunders, Philadelphia, pp 1113–1143

    Google Scholar 

  8. Hadler NM (1998) “Primary Raynaud’s” is not a disease or even a disorder; it’s a trait. J Rheumatol 25:2291–2294

    CAS  PubMed  Google Scholar 

  9. Wigley FM (2002) Raynaud’s phenomenon. N Engl J Med 347:1001–1008

    PubMed  Google Scholar 

  10. Valter I, Maricq HR (1998) Prevalence of Raynaud’s phenomenon in 2 ethnic groups in the general population of Estonia. J Rheumatol 25:697–702

    CAS  PubMed  Google Scholar 

  11. Belch JJF, Khan F (1998) Primary Raynaud’s is a disease or a disorder: it is not merely a trait. J Rheumatol 25:2295–2297

    CAS  PubMed  Google Scholar 

  12. Maricq HR, Carpentier PH, Weinrich MC et al (1997) Geographic variation in the prevalence of Raynaud’s phenomenon: a 5 region comparison. J Rheumatol 24:879–889

    CAS  PubMed  Google Scholar 

  13. Roman Ivorra JA, Perales JLG, Carballido CF, Grana J, Torres MJ (2001) Prevalence of Raynaud’s phenomenon in general practice in the east of Spain. Clin Rheumatol 20:88–90

    CAS  PubMed  Google Scholar 

  14. Silman A, Holligan S, Brennan P et al (1990) Prevalence of symptoms of Raynaud’s phenomenon in general practice. Br Med J 22:590–592

    Google Scholar 

  15. O’Keefee ST, Tsapatsaris NP, Beetham WP Jr (1993) Association between Raynaud’s phenomenon and migraine in a random population of hospital employees. J Rheumatol 20:1187–1188

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Yüzüncü Yil University School of Medicine, Ískele Cad. Altingöl Bloklari. A Blok. No: 84/10, 65200, Van, Turkey

    Kevser Onbaşi, Ídris Şahin, Yusuf Üstün & Doğan Koca

  2. Internal Medicine Unit of State Hospital, Van, Turkey

    Okan Onbaşi

Authors
  1. Kevser Onbaşi
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Ídris Şahin
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Okan Onbaşi
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Yusuf Üstün
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Doğan Koca
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Kevser Onbaşi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Onbaşi, K., Şahin, Í., Onbaşi, O. et al. Raynaud’s phenomenon in a healthy Turkish population. Clin Rheumatol 24, 365–369 (2005). https://doi.org/10.1007/s10067-004-1045-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-004-1045-x

Keywords